Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Motivations for paediatric vaccine trial participation.

Hillson K. et al, (2023), Trials, 24

Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study.

Shah P. et al, (2023), Lancet Reg Health Eur, 32

External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised children.

Martin AJ. et al, (2023), Arch Dis Child

Impact of infection on proteome-wide glycosylation revealed by distinct signatures for bacterial and viral pathogens.

Willems E. et al, (2023), iScience, 26

Molecular correlates of vaccine-induced protection against typhoid fever.

Zhu H. et al, (2023), J Clin Invest, 133

Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature.

Habgood-Coote D. et al, (2023), Med

Direct inference and control of genetic population structure from RNA sequencing data.

Fachrul M. et al, (2023), Commun Biol, 6

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.

Costa Clemens SA. et al, (2023), Hum Vaccin Immunother, 19

Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trials.

Kelly S. et al, (2023), Trials, 24

Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.

Kazmin D. et al, (2023), NPJ Vaccines, 8

Biobanking and consenting to research: a qualitative thematic analysis of young people's perspectives in the North East of England.

van der Velden FJS. et al, (2023), BMC Med Ethics, 24

Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data

Feng S. et al, (2023), eClinicalMedicine, 61

Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature.

Jackson HR. et al, (2023), J Pediatric Infect Dis Soc, 12, 322 - 331

Emergency medical services utilisation among febrile children attending emergency departments across Europe: an observational multicentre study.

Tan CD. et al, (2023), Eur J Pediatr

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

Dold C. et al, (2023), Sci Transl Med, 15

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.

Kaplonek P. et al, (2023), Nat Immunol

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.

McCann N. et al, (2023), BMJ Open, 13

Adeno-associated virus 2 infection in children with non-A-E hepatitis.

Ho A. et al, (2023), Nature, 617, 555 - 563

Genomic investigations of unexplained acute hepatitis in children.

Morfopoulou S. et al, (2023), Nature, 617, 564 - 573

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).

Koen AL. et al, (2023), Vaccine

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?